Bulletin
Investor Alert

New York Markets After Hours

July 12, 2018, 12:55 p.m. EDT

Harry Boxer’s four health-care stocks to watch

In focus: Arbutus Biopharma, Marinus Pharmaceuticals, Neptune Technologies & Bioressources and OPKO Health

new
Watchlist Relevance
LEARN MORE

Want to see how this story relates to your watchlist?

Just add items to create a watchlist now:

  • X
    Arbutus Biopharma Corp. (ABUS)
  • X
    Marinus Pharmaceuticals Inc. (MRNS)
  • X
    Neptune Wellness Solutions Inc. (NEPT)

or Cancel Already have a watchlist? Log In

By Harry Boxer


DANIEL LEAL-OLIVAS/AFP/Getty Images

Health-care stocks continue to dominate our list of top charts to watch.

Arbutus Biopharma Corp. /zigman2/quotes/203237619/composite ABUS -2.28% jumped 25 cents, or 2.8%, to $9.05 on Tuesday on 597,300 shares traded, nearly double its average volume. The hepatitis-drug company announced updates on several key milestones ahead of its afternoon presentation at Roivant Pipeline Day in New York City. The stock last month broke out of a more than six-month base pattern, and is now in a steep rising channel. Next target is $10.50-$11. Support on any pullback would be $8.20-$8.25.

Marinus Pharmaceuticals Inc. /zigman2/quotes/208112000/composite MRNS +1.07% popped 63 cents, or 8.5%, to $8.04 on over 1 million shares traded Tuesday. The move came on no news from the developer of therapeutics to treat epilepsy and neuropsychiatric disorders. The stock, which bottomed in March after a three-month down move, had a particularly strong run in late May and early June, and has since consolidated. A break over the June 8 high of $8.25 could get the stock to next lateral resistance just under $10.

Neptune Technologies & Bioressources Inc. /zigman2/quotes/207537677/composite NEPT -2.26% edged up 18 cents to $3.23 on just under 800,000 shares traded Tuesday on no news. The Quebec-based wellness-products company saw its stock break out three weeks ago on news of a new multiyear agreement with Canopy Growth /zigman2/quotes/200603886/composite CGC +11.54% to provide extracted cannabis products. The stock has since been consolidating the gains, and needs to get over lateral resistance at around $3.45 to make another run at its June 20 high just under $4.50.

OPKO Health Inc. /zigman2/quotes/207441614/composite OPK +6.87% gained 27 cents to $5.79 on 9.3 million shares traded Tuesday. There was no news from the health-care company, which engages in the diagnostics and pharmaceuticals business. The stock, which has been rallying since releasing better-than-expected earnings in early May, has broken out of a multi-year downtrend, and looks poised for more upside. Next targets are $6.50, followed by $7.50.

See Harry’s video-chart analysis on these stocks.

The writer has no holdings in any securities mentioned.

Harry Boxer is founder of TheTechTrader.com, a live trading room featuring his stock picks, technical market analysis, and live chart presentations.

/zigman2/quotes/203237619/composite
US : U.S.: Nasdaq
$ 3.00
-0.07 -2.28%
Volume: 1.25M
Oct. 19, 2020 4:00p
P/E Ratio
N/A
Dividend Yield
N/A
Market Cap
$254.53 million
Rev. per Employee
$74,313
loading...
/zigman2/quotes/208112000/composite
US : U.S.: Nasdaq
$ 15.08
+0.16 +1.07%
Volume: 445,424
Oct. 19, 2020 4:00p
P/E Ratio
N/A
Dividend Yield
N/A
Market Cap
$455.79 million
Rev. per Employee
N/A
loading...
/zigman2/quotes/207537677/composite
US : U.S.: Nasdaq
$ 2.16
-0.05 -2.26%
Volume: 392,942
Oct. 19, 2020 4:00p
P/E Ratio
N/A
Dividend Yield
N/A
Market Cap
$243.47 million
Rev. per Employee
N/A
loading...
/zigman2/quotes/200603886/composite
US : U.S.: NYSE
$ 19.81
+2.05 +11.54%
Volume: 14.32M
Oct. 19, 2020 4:00p
P/E Ratio
N/A
Dividend Yield
N/A
Market Cap
$6.60 billion
Rev. per Employee
$115,039
loading...
/zigman2/quotes/207441614/composite
US : U.S.: Nasdaq
$ 4.59
+0.30 +6.87%
Volume: 17.87M
Oct. 19, 2020 4:00p
P/E Ratio
N/A
Dividend Yield
N/A
Market Cap
$2.88 billion
Rev. per Employee
$174,036
loading...

Harry Boxer is founder of TheTechTrader.com, a live trading room featuring his stock picks, technical market analysis, and live chart presentations.

This Story has 0 Comments
Be the first to comment
More News In
Investing

Story Conversation

Commenting FAQs »
Link to MarketWatch's Slice.